Tracrium

   
Google
 
Web NewDrugInformation.com

Tracrium


Drug - Tracrium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Atracurium Besylate
Multiple ingredients are in alphabetical order.

Strength - 10MG/ML
The potency of the active ingredient(s), Atracurium Besylate. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Tracrium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018831
The FDA assigned number to Tracrium. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Tracrium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 20, 1985
The date Tracrium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Tracrium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tracrium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Tracrium.

Tracrium